Respiratory Infections News

Use of antivirals to treat influenza in children remains low despite their wide availability and guidelines recommending their use, according to a study published in Pediatrics.

COVID-19 caused a surge in premature births in California that “fully disappeared” by 2022, likely because of vaccines, researchers reported in the Proceedings of the National Academy of Sciences of the United States of America.

When given together, Pfizer’s respiratory syncytial virus vaccine and the seasonal influenza vaccine generated robust immune responses and were well tolerated among older adults when coadministered, data from a recent study showed.

Prenatal vaccination protects infants from COVID-19 up to age 6 months, real-world study findings published in JAMA Network Open suggest. The study found that vaccination prior to pregnancy did not protect babies from the disease.

An outpatient antibiotic stewardship bundle initiative reduced unnecessary antibiotic prescribing for respiratory infections without increasing repeat health care contacts, a recent study showed.

Nearly half of infectious diseases fellowship programs were not filled on Match Day as the number of applicants declined despite an increase in certified ID programs, the Infectious Diseases Society of America announced.

We caught up with Mary Foote, MD, MPH, at IDWeek to ask how she got “Hooked on ID.”

A novel MRI technique showed brain microstructure changes in people who have had COVID-19, and it traced long COVID symptoms to specific networks of the brain, according to a study.

NEW YORK — In this video, Timothy R. Shope, MD, MPH, reviews COVID-19, influenza and respiratory syncytial virus for general pediatricians in outpatient clinics.

Levofloxacin was safe and reduced the risk for multidrug-resistant tuberculosis among children, adolescents and adults by 60% in two phase 3 trials, according to results presented at the Union World Conference on Lung Health.